|
|
|
1
Spring 2002 Page 2
|
|
|
Spring 2002 Page 4
Marta
Saenz de Santa Maria The
story of the Spanish support group started with two
families and their daughters' IP diagnosis. Like many
other families when first given an IP diagnosis, they
felt disoriented, uncertain and isolated. Searching for
IP on the internet brought these families to IPIF where
they learned of the Foundation and of each other. They
would spend hours on the phone sharing feelings, doubts,
realities and much more. When a third family showed up
thanks to IPIF, they decided to meet and since Susanne
Emmerich, the Founder and Executive Director of IPIF, was
flying to Spain a first meeting was arranged in
Barcelona. Since
the girls were very young and took up little room, these
families managed to stay in a private flat. That weekend
was so intense that these three families will stay
friends for life. During the day they met with Susanne.
At night, when the girls slept, they discussed ideas and
projects but had to abandon the possibility of setting up
a formal legal association. In Spain this requires a lot
of paper work, plus having a website. No one wanted to
use their private address because that person would then
receive all the mail and have all the work. They decided
to split Spain into three parts and assign each of the
families one section. A
brochure on IP was written and one of the families
committed to putting it on the web (www.euskalnet.net/jtena).
The brochure shows the phone numbers of these three
families and people are able to contact them either by
phone or by e-mail through Susanne. Many copies of this
brochure have been printed (on private printers) and
mailed to all the hospitals in Spain. Each family
undertook the work and the expense of their assigned
zone. The group is still working this way regarding
telephone and similar expenses. The next
year we chose a small village on the Mediterranean coast
for our meeting. The Town Hall allowed us to use the
school premises over the weekend, which was really good
for it poured cats and dogs. We also managed to get some
coverage from the local press. During the meeting we
talked about the discovery of NEMO, the gene which causes
IP, and we decided what actions to take. All of which
reinforced our feelings of friendship. We had now grown
to four families and a visitor: a woman from an
association we keep in touch with. This
association is called Syndrom and it has a web page:
www.webs.comb.es/syndrom.
Syndrom tries to bring together a variety of orphan
genetic diseases and works for what needs they may have
in common. When required, it puts people of a same
disorder in touch. It also offers professional
psychological support. One of the projects which we were
involved in along with Syndrom consisted of setting up a
database for IP (Syndrom would produce one for each main
disorder) to be placed at the Casualty Department of the
main paediatric hospital in Barcelona, giving advice to
doctors as to how to or not to act. We did this in
conjunction with doctors at the hospital. Last November,
also along with Syndrom, two IP families in cooperation
with the Hospital Sant Joan de Déu, in Barcelona,
gave a talk on how families feel when facing an orphan
disease diagnosis. That was part of a 2-day congress on
orphan diseases directed by the Genetics Service. What a
step forward this was, the medical profession listening
to what parents have to say! The
group has now grown to twenty families. Everyone who has
contacted the group has been informed of the Nemo gene
and the possibility of a genetic test. We realized that
most hospitals did not know about this possibility and
many tests would not have been done without our giving
them the information. We might not always reply to every
letter which is sent to us, and for this we apologize. We
are short of time. One contact was readdressed to HITS (a
family support network for those affected by
Hypomelanosis of Ito). We also were consulted by a local
authority requesting school recommendations. We do want
to keep in touch but it is difficult to implement.
Parents tend to keep their daughters' identity and
particulars as private as possible. Yet, they would like
to share experiences with families who have similar
problems or whose children are of the same age. If we do
not give out information to the group, the group cannot
benefit from it. People who contact the group do not seek
to find friendship, but help. And the question is whether
you can obtain help from an annual meeting. In order
to try and resolve these difficulties, we have posted a
forum on our web page. We hope this will work as an
easier way to communicate with everybody. You put up a
question, or comment, and everybody has the opportunity
to reply. This forum should work as our office, where we
could arrange for a virtual meeting to be held. We
should reconsider the organization of our group. The
initial division into zones is not ideal. Communication
sometimes fails among the three founding families. We had
left out Latin America. We had also left out
communication with IPIF and other support groups, which
requires knowledge of the English language. Some families
ask for translations of English material. There is a lot
of work to be done and we welcome all collaborations. To know that there is a Foundation which is taking
care of IP research is more than a relief, but it would
be unfair to leave all the work for them and call for
help only when needed. Our group will not give up and
will stand by IPIF as long as it exists. Washington Post The race to
find new uses for genetic discoveries is hindering the
usual exchange of information among university
researchers, according to a study. A majority
of geneticists say they increasingly are being denied
access to colleagues' data, a practice many say may be
slowing progress in genetics research. The reasons
given for withholding information included the cost and
effort of sharing and a desire to protect a researcher or
student's ability to publish his or her findings,
according to the study in todayÄôs
Journal of the American Medical Association. Some
scientists also do not share because they are trying to
protect their ability to market their research
commercially, said lead author Eric Campbell, who teaches
health care policy at Harvard Medical School and the
Institute for Health Policy at Massachusetts General
Hospital. Withholding
data may hinder scientists' ability to replicate the
results of published studies or pursue their own
research, and hurt the education of new scientists,
experts said. The survey
of 1,240 geneticists found that 47 percent said at least
one request for data on published research had been
denied in the preceding three years, while 12 percent
said they had denied a request for data on published
results during that time. Seventy-three
percent believed withholding slowed the rate of progress
in their field, and 28 percent reported being unable to
confirm published results because authors would not share
data.
4
Co-Founder Spanish Support Group
Last year we did not hold a meeting. The group
had grown. There were now 10 families who had given us
their address/phone number, so that we could contact
them. Other families had just phoned once and did not
leave any particulars. This is a pity for if something
new turns up, we cannot share it with them. If one wants
to bring ten families together, one needs to know how
many people plan to attend, to be able to search for
adequate premises. You cannot meet at a park and risk the
weather. Here is where we failed: it is impossible to
please everyone. You are afraid of setting a date and
people not showing up. We did not get the enthusiastic
response we had expected. It takes a lot of time and
money to phone all those who have no e-mail address.
January 23, 2002
Spring 2002 Page 5
Pascal Garcia How did the
association INCONTINENTIA
PIGMENTIA (France) start? 1) JUNE 2000 to
MARCH 2001 It all
started in June 2000. I was looking for a special unit
for IP for my daughter Lisa who was going to shortly be
eighteen years of age. I asked myself "Surely there must
be an association for Incontinentia Pigmenti to help me.
This is not possible"? But of course it was, there was
no association. I only had
to look on the Internet for what I wanted. I know that I
am lucky to have access to this new technology but even
if it had not been there I was prepared to knock on every
door until I found what I was looking for. The summer
of 2000 was spent looking for anyone familiar with this
rare genetic illness. After so many long nights in front
of the computer screen, I eventually came across details
of two mothers whose children were affected by this
illness, through the "Maison des Maladies Orphelines" in
Paris. This is where it all started......... We were now 3 families. At
the end of September 2000, I contacted a family in the
Nantes region (in the west of France). I had kept their
address which I had received in response to an
advertisement that I placed in a specialist magazine in
1995, in which I asked for families who were affected by
Incontinentia Pigmenti to contact me. Now we were 4 families. On
the 6th of October 2000, a 10-minute was
broadcast on French television during a popular health
program. Things started happening. Thankfully my Email
address, telephone number and street address where given
out during the program. Two to three days later I
received a letter from a family in the central region of
France who had also, some years earlier, attempted to set
up an organization. Unfortunately, due to the size of the
project and the distinct lack of interest by others they
were forced to admit defeat. And now we were 5. Anyway,
this family sent me a list containing the details of
people, who had contacted them in response to an
advertisement placed in a newsletter for a well known
French organization for the disabled. There were
seven families and I contacted them one by one. Some days
later, two more people got in touch by letter and
email. And then there were 14
families. In November of 2000, I again placed an
advertisement in another specialist newsletter. Three
more people responded. Another
person contacted us after being told about this
association by an existing member. We
now consisted of 18 families. At the end of 2000, two
other families joined in by hearing about us through more
indirect methods. One was a family and the other friend
and the other was told about us by someone living in
Belgium!!! We now
had 20 families and so decided to work together and
really start to make progress on a new "Association".
There it is, the historic journey told. 2)
THE FOUNDATION of THE ASSOCIATION I.P. FRANCE: A SUMMIT
MEETING (March 30, 2001) 1. 10
a.m., in Paris, the meeting of 10 families in a
conference room loaned by the federation of rare illness
associations: At 10
o'clock we were nearly complete, barring a family which
had been affected by a strike of railway workers. After
about one hour of introductions and sharing of
photographs of our children, we sat around a large
conference table and began to discuss two major issues.
The creation of the association's head office and
clarification of its statutes. At midday
there was a pause for lunch and a chance to get to know
each other better. Then the discussion resumed and we
discussed in greater detail the finer points made
apparent during the course of the morning. Dr. Smail
Hadj-Rabia showed us around the location, followed by the
medical team giving us a presentation on I.P. Dr.
Christine Bodemer, dermatologist and geneticist, started
the meeting followed by Dr. Smail. His approach was to
take some chalk and draw a few schemes and tables on the
board to explain the NEMO gene, comparing it to an
appartment. It showed us the trials and tribulations, its
certainties, its questions. Asmae
Smahi, the co-discoverer of the NEMO gene which causes
IP, explained the research taking place and the hopes
that were created by the discovery. This was
when Professor Arnold Munnich appeared in the doorway to
present and introduce Susanne Emmerich, of the United
States, the founder and Executive Director of the
Incontinentia Pigmenti International Foundation (IPIF).
Dr. Pierre Vabres, dermatologist and geneticist at
Poitiers Hospital (in the west of France), formerly
attached to the Necker Hospital, was excellent in
translating Susanne's speech, which she gave in English,
in which she spoke of her personal reasons for her
involvement in IP. Dr. Smail
finished by showing us the laboratories dedicated to
genetic disease research, mitochondria, certain
neurological illnesses, pre- implantation diagnosis, and
working in close collaboration with another hospital and
the laboratory that holds all human material available
for the research, and finally the lab where he eventually
carries out pre-natal testing. It was more
than just scientific data that they presented, they
expressed emotion, compassion and an open mind throughout
the whole time we were there. 3. 8.30 p.m., The end of the day in
the restaurant "le Bistrot de Vaugirard." Professor Arnold Munnich once again
went beyond the call of duty and invited us all to dinner
in a restaurant that he had previously booked both for us
and for the members of the International I.P. Research
Consortium, who also happened to be in Paris for the
weekend. What a good
host he made, he held the door open and welcomed us all
in one by one and made sure that we were all
comfortable. Once
inside, he introduced us to the Italian researchers and
his colleague Dr. Michele d'Urso. Two days later we
learned that Dr. Asmae Smahi had achieved the standard to
be accepted into l'I.N.S.E.R.M (National Institute for
Medical Research). Congratulations. We hope that now she has her foot firmly on the ladder
and that Dr. Smahi will be able to continue her excellent
research in IP that she started so many years ago. We
also hope that the Italians, the Germans and the
Americans will continue their research, although they had
to leave us before the close of the meeting. 3)
EVOLUTION FROM MARCH TO NOVEMBER 2001 10 new
cases as follows: April 2001 1 IPIF May 2001 1 FMO June 2001 2 FMO July 2001 2 FMO August 2001 1 IPIF September 2001 2 Orphanet October 2001 1 Other IPIF
-- Incontinentia Pigmenti International Foundation (USA)
web site. FMO
-- Federation des Maladies Orphelines (Federation for
Orphan Diseases) ORPHANET
-- Web site containing a database of rare illnesses. This
brought the total of individuals and families to 30. This
represents 45 members to the association up through
November 30, 2001. A. Meeting to share up-to-date medical information The meeting
of December 1 took place in the all new library (offered
by Dr. Munnich) in Necker Hospital and was hosted by Dr.
Smail Hasj-Rabia. More than fifty people attended
(to our surprise, it must be said). There was a sharp
increase in membership bringing the number to 88
members through December 31, 2001. It must be
said that we were able to confidentially contact 80
families thanks to the administration staff of Dr. Arnold
Munnich. The response was well beyond our
expectations. B. Social and psychological support One of the
associationÄôs objectives is to offer
"social" support to our subscribers. This was one of the
principal tasks of the organization in 2001. This was to
try to resolve issues regarding government benefits for
handicapped people and school integration. There was a
lot of work to do. There is
also psychological help to be offered to members. This is
difficult to measure due to the long time periods
involved on the telephone trying to resolve the pain and
depression associated with an unknown rare illness that
has no cure. What a
relief it will be for families when they discover during
a genetic consultation that a pre-natal diagnosis
exists. 5)
SCIENTIFIC ENVIRONMENT The
Science Council The council consists of 5 people: Professor Arnold Munnich These professionals are based at the
Necker Hospital except for Doctor Vabres who is based at
Poitiers University Hospital. I can not
stress enough the importance of the Science Council's
role. The receptiveness and kindness that has been
experienced by everyone who has had the pleasure of
meeting them is most heartening. The
feedback from families that we have referred to Necker
Hospital and the genetic consultations they received only
goes to prove their availability, easy listening and
kindness as well as the display of excellent medical
competence. It would be
impossible for the association to function without these
people. The help provided by the translation of the
American IP website provided by Dr. Vabres is also
greatly appreciated. In fact, it
is an incredible opportunity for our association to be
able to benefit so much from these services. 6)
COMMUNICATION The
media The
association
is presented on the ORPHANET®
website and can be found in the section "Allô
Gênes". The
objective is to acquire and maintain our own web site.
But there is still so much work to do. Two members
are currently translating the American pages into French.
The work is nearly complete. This is
helping us to find even more information and ideas for
our website. There is also the association's newsletter
"The Gazette" which appeared in July 2001. The first
edition was sent to subscribers, donors and people that
are indirectly affected by this disease and seemed to
have been greatly appreciated. 7)
SUMMARY The
association is in a very dynamic and continuously growing
state not only in the way it works but also in the amount
of interest being generated by its members and
counselors. There are
so many ideas, too many perhaps, and it is already
necessary to review the priorities in order to be able to
achieve all the objectives and become even greater in
numbers. The first
nine months of the association (March to December 2001)
could easily be compared to the nine months of
pregnancy. The "baby"
is born, the parents are proud, now we need to
concentrate our efforts for the long term and to share
the tasks using everybody's abilities, motivation and
their availability for the best. To summarize, I think and I am convinced, we should
give our children a good education.
President
INCONTINENTIA PIGMENTI FRANCE
Who are its members?
Why are we here?
Like any life story, the association has its own
history.
Well, here it is, Once upon a time............
2. 4 p.m., Necker Hospital, Lavoisier Wing,
Genetic Research under the instruction of Professor
Munnich.
4) MEMBERS SUPPORT
December 1, 2001.
Professor Christine Bodemer
Doctor Asmae Smahi
Doctor Pierre Vabres
Doctor Smaïl Hadj-Rabia
Spring 2002 Page 6
Professor,
Department of Molecular and Human Genetics Walter H.
Stern For all the
questions yet to be answered and research yet to be done,
David L. Nelson marvels at the transformation that has
already changed the prospects of those with IP. From a
mysterious ailment many people didn't even know they had,
to a well-defined genetic mutation for which prevention
and remedy now loom on the distant horizon, IP has become
a mission to which he has devoted an increasing portion
of his time and energy. Dr, Nelson
has been at Baylor College of Medicine in Houston, Texas
for the past 16 years. He is currently Professor of
Genetics. He is also a member of the International IP
Research Consortium, created by the Incontinentia
Pigmenti International Foundation (IPIF) which identified
the NEMO gene two years ago. "It sort of
fell into my lap," Dr. Nelson tells of his involvement
with IP research. Because physicians rotate their
laboratory affiliations, Dr. Angela Scheuerle, a research
physician, took her investigative projects to Dr.
Nelson's lab at Baylor, where she sparked his awareness
of the disorder. Indeed, for
lack of a formal title, the facility is known simply as
"The Nelson lab." Most of his work there concentrates on
genes of the X chromosome, particularly as they affect
mental retardation. Dr. Richard A. Lewis, an
ophthalmologist at Baylor (and a member of the Scientific
Advisory Council of IPIF as well as a member of the
Research Consortium) had initiated IP research at Baylor,
and Dr. Scheuerle had taken on the project with Drs.
Lewis and Nelson. "IPIF
greatly facilitated our work and had a profoundeffect on
its progress," Dr. Nelson reports. "It helped us get over
the hump of building trust." By this he means that
genetic researchers, accustomed to professional rivalry
in their work, began constructive cooperation toward
their common goal under the aegis of IPIF. This, he
explains is no mean achievement in its own right. Asked how
he ranks IP in the scheme of health problems, he grew
somewhat ambivalent. On the one hand, he said, IP is
hardly a scourge in that it affects only one in 40,000 to
50,000 people. On the other, he says when you consider
that it is lethal to virtually all male fetuses; it is
nothing less than a dread disease. Moreover, the severity
of symptoms varies widely and, in any event, IP is still
"under diagnosed." Without
trying to hold out false hopes to women with IP who
hesitate to bear children for fear of passing IP along to
them, Dr. Nelson postulates that there is some promise in
the process of in-vitro fertilization.
In-vitro, he explains, offers the possibility
that, of the embryos created this way, experts can cull
out one that does not carry the NEMO mutation and thus
produce a few free of IP. "But this idea may not suit
everyone," he cautions. Indeed, Dr.
Nelson's curriculum vitae is an impressive compendium of
scientific achievements, writings and collaborations that
bids to foreclose much interest for things outside his
laboratory. Apparently, this is the story of his
professional life which began with bachelor's degrees in
biology and chemistry from the University of Virginia in
1978 and a doctorate in biology from MIT six years
later. That career
path had its origin early in Dr. Nelson's life. He
remembers always having had a lively interest in science,
sparked all the more by a "terrific biology teacher" in
high school who inspired him to take an optional second
year in science. But where next? Dr. Nelson
candidly admits that the prospect of pre-med courses in
college "turned me off. Everyone was so focused on just
one thing -- getting into med school. It wasn't for me,"
he says. Nor was he enthusiastic about a future of
spending his life in medical practice. Research held the
real charms for him. While
medical research is a broad field, Dr. Nelson again
attributes his specialization to the influence of an
advisor in his post-graduate work who opened up an
exciting vista in human genetics. In terms of
accomplishments, this advice has paid off. At 45 years of
age, Dr. Nelson has held a dozen leadership positions at
Baylor and written, co-authored or edited more than100
publicatiions on the subject, about one-third of them as
the prime author. "You have
to remember," he cautions modestly, "that the first draft
of many of these publications is the work of
post-graduate students; it's exciting for them and it's
really a part of their training." And yet,
within the scope of his career, IPIF plays a special
role. It is, in fact, the only formal international
consortium in which he has participated, although he did
join in a more ad hoc effort by a group that
identified genes mutated in Fragile X syndrome that can
cause mental retardation, and in Lowe syndrome which
causes eye disorders. While his
family is from Minneapolis, he spent his formative years
in the Virginia suburbs of Washington, where his father
was a lawyer at the Navy Department. His wife, Claudia,
hails from Chicago and is professionally active as a
petroleum geologist. No wonder, Dr. Nelson finds little
time or interest in such hobbies as golf, tennis or
sailing. But when he
and his wife do manage to carve out a vacation together,
they prefer a bit of family travel, such as a recent trip
to England or such Meccas as Yellowstone National
Park. Family ranks high on their agenda. And, Dr. Nelson
believes he has detected an orientation toward science in
his older son already. IPIF
is grateful to its supporters for their ongoing
generosity. IPIF is completely run by volunteers,
therefore there are no administrative expenses. IPIF
needs your contributions now to continue its valuable
work, the services it provides, as well as funding the
expenses of the International IP Research Consortium. Raising
funds for a rare disorder is extremely difficult.
Most public foundations wish only to fund the larger,
better-known health organizations, usually those which
are receiving the most publicity. As
ground-breaking as the identification of the gene NEMO
that causes IP was, there were no newspapers in the U.S.
willing to carry the story. Even government agencies have
refused financial support. Therefore, it is up to the
families, friends and relatives of those with IP to
help. If
you have not become a member, or have not renewed your
membership please consider doing so. Several
individuals have taken the opportunity to make a gift in
honor of a deceased friend or loved one, or sent in a
contribution to celebrate a special occasion such as a
birthday, anniversary, graduation, etc. When such a
contribution is made a letter is sent, to the family
being so honored, acknowledging the contribution. One
may also consider giving a fund-raising event such a tea
party, cocktail party, auction, etc. Please keep in mind that whatever the reason, your
contribution is essential.
6
Baylor College of Medicine
"I find this work very gratifying," Dr. Nelson
says. So satisfying, he admits, that this and his
countless other research projects leave him little time
for the trivial pursuits that engage men and women in
other fields. There is no time, for instance, to be
a Little League coach, but he does watch the older of his
two sons play ball.